Conference abstract · 15 Jun 2026
Conference abstractPublished 21 Jul 2014
Cosmeceuticals
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Cosmeceuticals represent the fastest growing area in dermatology. Dermatologists are in a good position to help patients understand the benefits and realistic limitations of these products. Regulatory frameworks differ significantly between the different markets and are far from being synchronized. The principal activity of the study and its scope: This study will provide an important step towards understanding current situation of cosmeceutical products. This is a coherent project making recommendation for strategic way related to improving vigilance, consumption and efficacy issues of cosmeceuticals. Methodology: A literature search was carried out between February and March 2013 in Medline, Pub Med, Web of knowledge, Scopus, Google scholar and the Cochrane Library databases with no time limit. References cited in published articles were examined until no further study was identified. All English, animal and human studies were included. Results: Research in this field, especially in the context of dermatologists? training, is particularly scant and needs to be improved. This project gives an insight to the industry and dermatology curriculum builders that there is strong need to develop the training spectrum in cosmeceuticals. Moreover, there are no synchronized guidelines. EU, Japan and Canada are major contributors in regulatory system. Conclusion or Recommendation: The confusing and contradicting global regulatory definitions of cosmeceuticals emphasize the need of harmonized guidelines or a synchronized regulatory framework. There is a need to improve dermatologists? knowledge and confidence about cosmeceuticals? ingredients safety and efficacy through various up-to-date/ evidence-based seminars, workshops and training courses. There should be common guidelines, e.g. for approaches to safety testing, particularly regarding alternatives to animal testing. Increase high quality basic and clinical research in cosmeceuticals will boost this rapidly developing area. Through means of these measures the establishment of an evidence-based cosmetic dermatology can be achieved. This project may serve as a tool for assisting future studies and primary research in this field.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 11 Dec 2024
Cosmeceuticals: Bridging the Gap Between Skincare and Pharmacology
Research article · 25 Apr 2022
Evaluation of Effectiveness and Tolerance of a Cosmeceutic Regimen Based on Topical Retinoids
Conference abstract · 26 Nov 2018
Cosmetic skincare VS cosmeceuticals - Why to choose cosmeceuticals ?
Conference abstract · 7 May 2018
Possibility for use as a cosmeceutical material of reduction-responsive Monoolein cubic phase containing epidermal growth factor
More from this journal
The newest in Journal of Clinical & Experimental Dermatology Research.
Research article · 30 Jul 2026
MINIMALLY-INVASIVE LASER-ASSISTED (MILA) FACELIFT UNDER LOCAL ANESTHESIA
Commentary · 30 Jul 2026
Breaking the Stigma Around Psoriasis: A Broader View of Chronic Skin Disease
Perspective · 28 Jul 2026
Acne as More Than a Cosmetic Concern: A Personal and Medical Perspective
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Dermatology Research
- SubjectDermatology
- BylineArticles whose byline prints “Huma Khurrum”

